From science to markets
The strongest opportunities emerge where breakthrough science meets strategic demand, regulatory change and a credible pathway to adoption.
Founder & Managing General Partner of R3i, I invest in and build frontier-technology companies with proprietary science, defensible intellectual property and credible pathways to institutional adoption — across AI, deep tech, health, climate and critical minerals, operating across Europe, Asia-Pacific, Australia and North America.
The strongest opportunities emerge where breakthrough science meets strategic demand, regulatory change and a credible pathway to adoption.
Defensible intellectual property, trusted data, regulatory readiness, procurement discipline and operating resilience determine whether technical advantage can withstand institutional scrutiny.
Frontier companies need more than financing. They need clarity on what to prove, which risks to retire, where to partner and when to move.
As AI becomes increasingly accessible, we underwrite what remains scarce: proprietary science, patents and protected intellectual property, validated evidence, regulated workflows, manufacturing capability and strategic distribution.
Sectors where technical advantage depends on infrastructure, policy, security and institutional adoption.
R3i · R3i Ventures · Planet43 · TRIUM Angels · Vena (European Critical Minerals)
Europe · Asia-Pacific · Australia · North America
“Leesa works exceptionally hard to support founders and connect the right people. I have worked with several tier-one venture-capital partners, and Leesa's impact is above anyone I have had the pleasure of working with. She is a model of what a founder should want in an investor.”
“The energy, knowledge and connections Leesa brought to our deep-tech company were invaluable. She combines commercial judgement, a deep understanding of the global investment landscape and an exceptional willingness to help, while fostering ambition, cooperation and confidence across the team.”
Co-investment, pre-IPO access and strategic partnerships across R3i's frontier-technology portfolio.